188 related articles for article (PubMed ID: 31499040)
1. Liver and insulin resistance: New wine in old bottle!!!
Patel BM; Goyal RK
Eur J Pharmacol; 2019 Nov; 862():172657. PubMed ID: 31499040
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
3. The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome.
Jornayvaz FR; Samuel VT; Shulman GI
Annu Rev Nutr; 2010 Aug; 30():273-90. PubMed ID: 20645852
[TBL] [Abstract][Full Text] [Related]
4. Skeletal muscle insulin resistance is fundamental to the cardiometabolic syndrome.
Nistala R; Stump CS
J Cardiometab Syndr; 2006; 1(1):47-52. PubMed ID: 17675899
[TBL] [Abstract][Full Text] [Related]
5. SIRT1 and insulin resistance.
Cao Y; Jiang X; Ma H; Wang Y; Xue P; Liu Y
J Diabetes Complications; 2016; 30(1):178-83. PubMed ID: 26422395
[TBL] [Abstract][Full Text] [Related]
6. Targeting the liver in the metabolic syndrome: evidence from animal models.
Petruzzelli M; Lo Sasso G; Portincasa P; Palasciano G; Moschetta A
Curr Pharm Des; 2007; 13(21):2199-207. PubMed ID: 17627553
[TBL] [Abstract][Full Text] [Related]
7. Unraveling the mysteries of hepatic insulin signaling: deconvoluting the nuclear targets of insulin.
Kitamoto T; Accili D
Endocr J; 2023 Sep; 70(9):851-866. PubMed ID: 37245960
[TBL] [Abstract][Full Text] [Related]
8. Hepatic lipid metabolism and non-alcoholic fatty liver disease in aging.
Gong Z; Tas E; Yakar S; Muzumdar R
Mol Cell Endocrinol; 2017 Nov; 455():115-130. PubMed ID: 28017785
[TBL] [Abstract][Full Text] [Related]
9. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.
Lewis GF; Carpentier A; Adeli K; Giacca A
Endocr Rev; 2002 Apr; 23(2):201-29. PubMed ID: 11943743
[TBL] [Abstract][Full Text] [Related]
10. Revisiting the metabolic syndrome: the emerging role of aquaglyceroporins.
da Silva IV; Rodrigues JS; Rebelo I; Miranda JPG; Soveral G
Cell Mol Life Sci; 2018 Jun; 75(11):1973-1988. PubMed ID: 29464285
[TBL] [Abstract][Full Text] [Related]
11. Prolonged PM2.5 exposure elevates risk of oxidative stress-driven nonalcoholic fatty liver disease by triggering increase of dyslipidemia.
Xu MX; Ge CX; Qin YT; Gu TT; Lou DS; Li Q; Hu LF; Feng J; Huang P; Tan J
Free Radic Biol Med; 2019 Jan; 130():542-556. PubMed ID: 30465824
[TBL] [Abstract][Full Text] [Related]
12. Insulin action in morbid obesity: a focus on muscle and adipose tissue.
Mitrou P; Raptis SA; Dimitriadis G
Hormones (Athens); 2013; 12(2):201-13. PubMed ID: 23933689
[TBL] [Abstract][Full Text] [Related]
13. Skeletal muscle-specific deletion of lipoprotein lipase enhances insulin signaling in skeletal muscle but causes insulin resistance in liver and other tissues.
Wang H; Knaub LA; Jensen DR; Young Jung D; Hong EG; Ko HJ; Coates AM; Goldberg IJ; de la Houssaye BA; Janssen RC; McCurdy CE; Rahman SM; Soo Choi C; Shulman GI; Kim JK; Friedman JE; Eckel RH
Diabetes; 2009 Jan; 58(1):116-24. PubMed ID: 18952837
[TBL] [Abstract][Full Text] [Related]
14. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.
Parekh S; Anania FA
Gastroenterology; 2007 May; 132(6):2191-207. PubMed ID: 17498512
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptors and the metabolic network.
Barros RP; Gustafsson JÅ
Cell Metab; 2011 Sep; 14(3):289-99. PubMed ID: 21907136
[TBL] [Abstract][Full Text] [Related]
16. Insulin action and resistance in obesity and type 2 diabetes.
Czech MP
Nat Med; 2017 Jul; 23(7):804-814. PubMed ID: 28697184
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
18. [Current views on the metabolic syndrome and the effects of antipsychotic drugs].
Fodor M
Psychiatr Hung; 2011; 26(3):196-200. PubMed ID: 21799222
[TBL] [Abstract][Full Text] [Related]
19. New drug targets for type 2 diabetes and the metabolic syndrome.
Moller DE
Nature; 2001 Dec; 414(6865):821-7. PubMed ID: 11742415
[TBL] [Abstract][Full Text] [Related]
20. Lycopene Improves Insulin Sensitivity through Inhibition of STAT3/Srebp-1c-Mediated Lipid Accumulation and Inflammation in Mice fed a High-Fat Diet.
Zeng Z; He W; Jia Z; Hao S
Exp Clin Endocrinol Diabetes; 2017 Oct; 125(9):610-617. PubMed ID: 28472825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
